5 resultat
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a national stage of international application no. PCT/JP2009/050018, filed on Jan. 6, 2009, and claims priority under 35 USC 119 to Japanese application no. 2008-003072, filed on Jan. 10, 2008, which are incorporated herein by
FIELD OF THE INVENTION
This invention relates to the treatment and prevention of fever blisters (cold sores) and canker sores. More particularly the invention relates to a method for treatment and prevention of fever blisters and canker sores using, as a basis, the protective properties of
BACKGROUND OF THE INVENTION
The present invention is novel compounds which are 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidine substituted 1,2,4- and 1,3,4-thiadazoles and oxadiazoles, and 1,2,4-triazoles, and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical
BACKGROUND OF THE INVENTION
The present invention is novel compounds which are 4,6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidine substituted 1,2,4- and 1,3,4-thiadazoles and oxadiazoles, and 1,2,4-triazoles, and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical
The present invention relates to pharmacy and industrial bulk solution package of melatonin, an highly concentrated and versatile solution of melatonin in a substantially water-free carrier mixture of ethanol and polyethoxylated derivative, admixed in an optimal ratio to almost double melatonin